Pyruvate carboxylase (E.C. 6.4.1.1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PCp0'"""* deficiency). Lymphocyte activities were: mother, 33-3%; father, 11-2976; brother, 82-103% and sister, 38-48% of the lowest normal. Fibroblasts from the patient's mother and father had 42 and 3496, respectively, of the activity of the lowest normal. These data demonstrate that the disease is inherited in an autosoma1 recessive manner and that lymphocytes and fibroblasts can be used to detect carriers. Neither pyruvate carboxylase nor mitochondrial PEPCK activity in lymphocytes was increased by a 21-hr fast. Speculation plasma (12) and bacteria were negative. The lymphocyte plus monocyte or mixed leukocyte fractions were isolated as described (4) from whole venous blood. Care was taken to eliminate donors that were obese, malnourished, had diabetes mellitus or a family history of the same, were on "unusual" diets or were receiving any medication. Some of the women were, however, taking birth control pills. The donors were instructed that the meal to be eaten before venipuncture should be "balanced" with respect to protein, fat, and carbohydrate. Most donors were assayed for mitochondrial phosphoenolpyruvate carboxykinase (E.C.4.1.1.32, PEPCK) and citrate synthase (E.C.4.1.3.7) in addition to pyruvate carboxylase. Two controls of the same sex and approximate age (controls were about 1 yr older than the patient) as the patient were tested. Pyruvate carboxylase and mitochondria1 PEPCK were assayed by a modification (4) of the methods of Utter and Keech (13) The demonstration that carriers of pyruvate carboxylase defi-3:s'-dithiobis(2-nitrobenzoatd) to mkasure the releasiof free CoAciency can be detected with a venous blood sample may allow, with SH. Protein was determined by the method of Lowry et al. (9) . All the use of extensive family studies, the assignment of this enzyme reagents were of the grade and source designated in the earlier to a chromosomal linkage group. publication (4). All blood samplings and assays of suspected carriers of, or patients with pyruvate carboxylase deficiency were accompanied by the simultinkous sampling and assay of a known Pyruvate carboxylase deficiency (2, 3, 6, 71, an inborn error of normal. All skin biopsies and blood samples were obtained with pyruvate metabolism, usually results in severe developmental and informed consent. mental retardation, lactic acidosis and, in at least one case (2, 3) proximal renal tubular acidosis. Until recently, diagnosis of the RESULTS disease has been possible only from a liver biopsy and this has precluded family studies and prenatal diagnosis. However, the The data in Table 1 demonstrate that fasting for 4, 8, or 21 hr recent development by Atkin et 01. (4) of an assay for pyruvate had no significant effect on lymphocyte PYruvate carbox~lase carboxylase in cultured skin fibroblasts and circulating peripheral activity when blood was drawn at the same time of day (3:30-4:00 lymphocytes has allowed for the first time the detection of pyru-PM). However, the mean and range of lymphocyte PYruvate vate carboxylase deficiency in the leukocytes and fibroblasts of a carboxylase activities of 7 samples drawn at 9 AM (15 hr Postpatient with hepatic, renal cortical, and cerebral pyruvate carbox-prandial) were appreciably lower than the mean and range of ylase deficiency. DeVivo et al. (6) also demonstrated pyruvate Samples drawn at 3:304:00 PM, whether 4, 8, or 21 hr PoStPrancarboxylase deficiency in the fibroblasts of a patient with hepatic dial. Lymphocyte mitochondrial PEPCK activities in blood drawn pyruvate carboxylase deficiency (PC" L""'" deficiency) and re-at 9 AM (15 hr postprandial) were also lower than those drawn at duced pyruvate carboxylase activity in fibroblasts from that pa-3:3@4:00 PM (4 hr postprandial) ( Table 1) . Neither fasting nor tient's parents. In the present study, examination of fibroblasts time of day had any consistent effect on the activity of lymphocyte and lymphocytes from the parents of the patient with p~Pofi1a"d citrate synthase (Table I) . Pyruvate carboxylase activity in the deficiency and of lymphocytes from the patient's two mixed leukocytes of three normal adults was 0.089 f 0.012 munits/ siblings establish the mode of inheritance of pyruvate carboxylase mg mononuclear leukocyte protein and in two normal children deficiency. Furthermore, this study demonstrates that either fibro-(5 Yr old) was 0.089 * 0.005 (0.0843 0.094) munits/mg mononublasts or lymphocytes may be useful in the detection of carriers of clear leukocyte protein. ,411 the above had leukocytes drawn at 3-pyruvate carboxylase deficiency.
Summary
Pyruvate carboxylase (E.C. 6.4.1.1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PCp0'"""* deficiency). Lymphocyte activities were: mother, 33-3%; father, 11-2976; brother, 82-103% and sister, 38-48% of the lowest normal. Fibroblasts from the patient's mother and father had 42 and 3496, respectively, of the activity of the lowest normal. These data demonstrate that the disease is inherited in an autosoma1 recessive manner and that lymphocytes and fibroblasts can be used to detect carriers. Neither pyruvate carboxylase nor mitochondrial PEPCK activity in lymphocytes was increased by a 21-hr fast. Speculation plasma (12) and bacteria were negative. The lymphocyte plus monocyte or mixed leukocyte fractions were isolated as described (4) from whole venous blood. Care was taken to eliminate donors that were obese, malnourished, had diabetes mellitus or a family history of the same, were on "unusual" diets or were receiving any medication. Some of the women were, however, taking birth control pills. The donors were instructed that the meal to be eaten before venipuncture should be "balanced" with respect to protein, fat, and carbohydrate. Most donors were assayed for mitochondrial phosphoenolpyruvate carboxykinase (E.C.4.1.1.32, PEPCK) and citrate synthase (E.C.4.1.3.7) in addition to pyruvate carboxylase. Two controls of the same sex and approximate age (controls were about 1 yr older than the patient) as the patient were tested. Pyruvate carboxylase and mitochondria1 PEPCK were assayed by a modification (4) of the methods of Utter and Keech (13) and Ballard and Hanson (5) . Citrate synthase was assayed as described bv Isohashi et 01. (8) bv a s~ectro~hotometric assav which uses . , 2 The demonstration that carriers of pyruvate carboxylase defi-3:s'-dithiobis(2-nitrobenzoatd) to mkasure the releasiof free CoAciency can be detected with a venous blood sample may allow, with SH. Protein was determined by the method of Lowry et al. (9) . All the use of extensive family studies, the assignment of this enzyme reagents were of the grade and source designated in the earlier to a chromosomal linkage group. publication (4) . All blood samplings and assays of suspected carriers of, or patients with pyruvate carboxylase deficiency were accompanied by the simultinkous sampling and assay of a known Pyruvate carboxylase deficiency (2, 3, 6, 71, an inborn error of normal. All skin biopsies and blood samples were obtained with pyruvate metabolism, usually results in severe developmental and informed consent. mental retardation, lactic acidosis and, in at least one case (2, 3) proximal renal tubular acidosis. Until recently, diagnosis of the RESULTS disease has been possible only from a liver biopsy and this has precluded family studies and prenatal diagnosis. However, the The data in Table 1 demonstrate that fasting for 4, 8, or 21 hr recent development by Atkin et 01. (4) of an assay for pyruvate had no significant effect on lymphocyte PYruvate carbox~lase carboxylase in cultured skin fibroblasts and circulating peripheral activity when blood was drawn at the same time of day (3:30-4:00 lymphocytes has allowed for the first time the detection of pyru-PM). However, the mean and range of lymphocyte PYruvate vate carboxylase deficiency in the leukocytes and fibroblasts of a carboxylase activities of 7 samples drawn at 9 AM (15 hr Postpatient with hepatic, renal cortical, and cerebral pyruvate carbox-prandial) were appreciably lower than the mean and range of ylase deficiency. DeVivo et al. (6) also demonstrated pyruvate Samples drawn at 3:304:00 PM, whether 4, 8, or 21 hr PoStPrancarboxylase deficiency in the fibroblasts of a patient with hepatic dial. Lymphocyte mitochondrial PEPCK activities in blood drawn pyruvate carboxylase deficiency (PC" L""'" deficiency) and re-at 9 AM (15 hr postprandial) were also lower than those drawn at duced pyruvate carboxylase activity in fibroblasts from that pa-3:3@4:00 PM (4 hr postprandial) ( Table 1) . Neither fasting nor tient's parents. In the present study, examination of fibroblasts time of day had any consistent effect on the activity of lymphocyte and lymphocytes from the parents of the patient with p~Pofi1a"d citrate synthase (Table I) . Pyruvate carboxylase activity in the deficiency and of lymphocytes from the patient's two mixed leukocytes of three normal adults was 0.089 f 0.012 munits/ siblings establish the mode of inheritance of pyruvate carboxylase mg mononuclear leukocyte protein and in two normal children deficiency. Furthermore, this study demonstrates that either fibro-(5 Yr old) was 0.089 * 0.005 (0.0843 0.094) munits/mg mononublasts or lymphocytes may be useful in the detection of carriers of clear leukocyte protein. ,411 the above had leukocytes drawn at 3-pyruvate carboxylase deficiency.
4 PM when individuals were about 3% hr postprandial. Two normal adults whose blood was drawn at 9:30 AM (15 hr post-
MATERIALS AND METHODS
prandial) had values of 0.047 and 0.042 munits/mg mononuclear leukocyte protein. One of these morning donors had a value of Fibroblasts were grown in Eagle's MEM with 10% fetal bovine 0.070 munits/mg mononuclear leukocyte protein when blood was serum, 1000 units/ml penicillin G and 50 pg/ml gentamycin, fed drawn in the afternoon. every 2-3 days and harvested, as described (4), 3-14 days past Lymphocyte pyruvate carboxylase activity for normals, the confluency. The control donors varied from t 3 days to 45 yr of patient's parents and brother and sister are shown in Figures I age and included both sexes. All tests of fibroblasts for myco-and 2. Pyruvate carboxylase activity in cultured skin fibroblasts Values are expressed as the mean f SEM ( I I ) followed by the range and number of control subjects (n). fixed/min at-37°C The following symbols are used:-normals (0); assays on five different blood samples drawn from the same normal subject over the period of a year (A); female carrier of pyruvate carboxylase deficiency (a); male carrier of pyruvate carboxylase deficiency (a); male examined for pyruvate carboxylase deficiency and found to be normal (Dl); and patient with pyruvate carboxylase deficiency (1). The dorred line indicates 5 W of the activity of the lowest normal. The mean of normals is marked by an arrow. The normals consist of I I different individuals some of whom had blood drawn at different times postprandial. However, all blood was drawn from 3:30-4:00 PM. from normals, the patient, and the patient's parents is shown in Figures 2 and 3 . The activity of mitochondrial PEPCK and citrate synthase in the lymphocytes and fibroblasts of the family members is given in Table 2 .
The activity of pyruvate carboxylase in the fibroblasts of the patient of DeVivo et al. (6) with P C~' .~" " deficiency and of that patient's parents is given in Figure 3 . The activities of mitochondrial PEPCK and citrate synthase in these fibroblasts are given in Table 2 . and that it might be responsive to one or more of those hormones regulating glucose homeostasis: insulin, glucagon, and catecholamines. There are conflicting reports with regard to this enzyme's response to these conditions, but the question must still be considered open. Also, the blood samples for pyruvate carboxylase were to be assayed for PEPCK and at the time of the initial blood samples, it was not known whether the lymphocyte PEPCK activity was due to the cytosolic or mitochondrial form of this enzyme and it had been well established that cytosolic hepatic PEPCK activity does increase in response to fasting (10) . Furthermore, lymphocyte pyruvate carboxylase, other than the studies of Atkin et al. (4), had never before been assayed and consequently the influence, if any, of different physiologic states such as fasting. or endogenous rhythms on the enzyme's activity was unknown. Initially, therefore, all blood samples were drawn either at 9:30 AM or 3 4 PM to reduct the possible effects of varying physiologic states on lymphotyte pyruvate carboxylase and PEPCK activity and care was taken to match the postprandial intervals for experimental and control subjects.
There was no significant difference in the mean or range of DETECTION of PYRUVATE CARBOXYLASE DEFICIENCY 1 103 pyruvate carboxylase activities obtained 4.8, or 2 I hr postprandial if the blood was drawn at 3:3&4:00 PM. There was, however, a possible effect of the time of day at which blood was drawn, on pyruvate carboxylase and PEPCK activity (Table I) . Citrate syn- thase exhibited no significant effect although the large variation in the activity of this enzyme may have obscured any trend. The possible existence of diurnal variation in pyruvate carboxylase activity is given support by the finding that the activity was higher in the leukocytes of five normals drawn in the afternoon than that of two normals drawn in the morning (See Results). Furthermore, these data contain one individual tested both in the afternoon and morning who exhibited decreased pyruvate carboxylase activity in the morning sample. The physiologic significance of this observation is different to evaluate. It is possible that the pyruvate carboxylase and PEPCK activities are actually lower in the morning as a result of an effect on enzyme activity by a diurnal hormonal rhythm(s). It is also possible that the population of lymphocytes plus monocytes is different in the morning than the afternoon. No attempt was made in this study to determine whether the pyruvate carboxylase and PEPCK activities are distributed equally among monocytes. T, and B lymphycytes. Thus.
the difference between morning and afternoon activities could reflect a difference in cell population. Because of the possible difference between morning and afternoon samples, only those determinations made on lymphocytes drawn in the afternoon were used to establish the normal range. The practical necessity of drawing the experimental and control blood samples at the same time of day is underscored by the finding of lymphocyte pyruvate carboxylase activities, from some presumed normals sampled in the morning. in the carrier range if the normal range were established with afternoon samples. Afternoon sampling of subjects has the advantage, furthermore. of providing a greater yield of white cells and, thus, permitting the drawing of a smaller blood sample. This is not a minor consideration when testing pediatric patients because the pyruvate carboxylase activity in the lymphocytes of a carrier is vanishingly small.
Although the patient's brother's two lymphocyte pyruvate carboxylase activities (0.099 and 0.079) were below the 68.3% confidence interval for normals, the existence of two normal values (0.096 and 0.098) (Fig. 1) below the patient's brother's higher value, make it unlikely that the brother is a carrier for pyruvate carboxylase deficiency. The sister, mother. and father with lymphocyte pyruvate carboxylase activities of 38-48. 33-39, and 1 I-29% respectively, of the lowest normal. clearly are carriers for pyruvate carboxylase deficiency (Figs. I and 2 ). Although the Table 2 Actrvrtres of mrtochondrral PEPCK and crtrate synthase in lymphocytes andfibroblasts oftwofamrlrer wrth pyruvate carboxylase ' munits of enzyme activity as described in the legend of Table 1 . Value are expressed as the mean * SEM ( I I ) for the number of assays on that tlssue in parentheses. If the tissue was only assayed once. the value represents the mean + SEM of the replicates of the assay from which replicate blanks were subtracted. The number of replicates for pyruvate carboxylase or PEPCK in lymphocytes or leukocytes was 6, for pyruvate carboxylase and PEPCK in fibroblasts. 4 and for citrate synthase. 2.
Assayed In mixed peripheral leukocytes, but corrected for mononuclear leukocyte content and activity expressed in terms of mg of mononuclear leukocyte protein ATKIN number of normals assayed was small, results of the assay in mixed leukocytes were entirely consistent with the findings from lymphocytes (Fig. 1) . That the reduced pyruvate carboxylase activities observed are genuine and not due to a transient phenomenon peculiar to one particular blood sample is demonstrated convincingly by the observation that the patient's brother was normal and the mother and sister camers, in two difFerent blood samples drawn more than 8 months apart and with different white cell isolation procedures.
The demonstration of reduced pyruvate carboxylase activity (34, 42, 67, and WO of the lowest normal) in the fibroblasts of obligate camers from two separate families with hepatic pyruvate carboxylase deficiency indicates that the observation of reduced pyruvate carboxylase activity in that tissue may be a common finding in this disease and not just peculiar to one case. However, more obligate camers must be examined before any conclusions can be drawn about the universality of this observation.
The mitochondrial PEPCK activity in leukocytes from the patient with PC~"*'"* deficiency is somewhat reduced, and is significantly reduced in the patient's fibroblasts (Table 2) . That this reduction is not common to all patients with pyruvate carboxylase deficiency, however, is shown by the normal or near normal PEPCK in the fibroblasts from the patient with P C~' .~" " deficiency. As was discussed (4), all the parameters for the proper assay of mammalian PEPCK may not be known and this may offer an explanation for the variation in observed values.
A comparison of the pyruvate carboxylase activities presented here with those of DeVivo et al. (6) for the fibroblasts from the family with PCSt. LOU" deficiency is worthy of comment. The present study confirms their finding of a def ciency in the patient and reduced activity in the parents, but the absolute values for patient, parents, and normals is different in the two studies. This difference in activity from laboratory to laboratory demonstrates the absolute necessity of establishing normal enzyme values in the same laboratory where patients or potential camers are to be examined. It also underscores the value of the Utter and Keech (13) Ballard and Hanson (5) assay of pyruvate carboxylase activity because without the extreme sensitivity provided by that method, the detection of carriers of pyruvate carboxylase deficiency in lymphocytes would be much more difficult, if possible at all.
The very low activity of lymphocyte pyruvate carboxylase requires rigorous attention to the details of the assay in order to determine carriers. However, with the use of this tissue, diagnosis is possible in 2-3 days and the individual is exposed to nothing more invasive than venipuncture. In contrast, the assay in fibroblasts requires the more invasive procedure of skin biopsy and several weeks to acquire fibroblasts. However, because fibroblasts contain about 10 times as much pyruvate carboxylase as do lymphocytes, and because as many fibroblasts can be grown as is required, the enzyme is easier to assay in that tissue. Fibroblasts have the further advantage of being several generations removed from the pathologic environment, in the case of a patient, and thus, one can be more certain that a reduced enzyme level is due to a genetic defect and not secondary to some other pathologic process as might be the case with circulating peripheral lymphocytes. Although it is possible to assay the lymphocyte pyruvate carboxylase in preparations of mixed leukocytes, the author prefers the use of the separated lymphocyte plus monocyte fraction. If pyruvate carboxylase deficiency is suspected in a patient, it would be wise to obtain both a skin biopsy, and a lymphocyte plus monocyte fraction, if possible.
